This week's
TOC Theater opener is brought to you by Microsoft Excel for Mac.
As I mentioned on the
TOC blog
nearly a year ago, a big chunk of my workweek is spent maintaining our master calendar of productions, processing the press releases that come in from companies all over town and entering them into the Excel spreadsheet that is, in large part, the engine that runs the magazine's theater section—we use it for everything from maintaining listings to scheduling reviews to generating story ideas. For this week, the Master List (as we affectionately refer to it in the office) suggested the story in a more literal sense. Every time I start entering a play title and author into a new row on the spreadsheet, Excel's Autofill feature tries to guess what I'm typing. More and more over the last several months, it's been exactly right—because the play was already on the calendar in a production by another company.
All told, there were six instances in the coming season of duplicate plays (it would have been seven if
The Gift Theatre hadn't swapped out their previously announced production of
Glengarry Glen Ross, which would have followed
Redtwist's current mounting, for David Rabe's
Streamers). In two cases, companies who had been the first to announce their productions as Chicago premieres—
Theatre Seven with Josh Tobiesson's
Election Day, and
BackStage with John Kolvenbach's
On an Average Day—were scooped by another company.
Multiple productions of Shakespeare's more popular plays are unsurprising, but two iterations of Peter Barnes's
Red Noses? Overlapping renditions of Pinter's
Old Times? This isn't a new problem—both
Deanna Isaacs in the Reader and
Kerry Reid in Performink wrote about the conflicting "premieres" of Noah Haidle's
Mr. Marmalade in the spring of ’07—but I decided to see if I could get to the bottom of this problem. And I do find it to be a problem: If a theater company can't announce a show for its season, particularly one it's hoping to be a Chicago premiere, without a guarantee that another company won't steal (or at least borrow some of) its thunder, that's a major headache for artistic directors and a potential disservice to audiences.
Happily, execs from licensing houses
Dramatists Play Service and
Samuel French agreed to interviews with me. I couldn't get hard answers from any of them, as both companies claim to make decisions on production rights and exclusivity (outside of New York or L.A. at least) largely on a case-by-case basis. Contrary to popular wisdom among the theater community, even Equity theaters aren't necessarily protected, as
Route 66 (the new, Stef Tovar-led Equity company that beat BackStage to the Kolvenbach play with its currently running production) and
Remy Bumppo (whose
Old Times will overlap with City Lit's production) demonstrate.
And the multiple-productions issue only scratches the surface of licensing issues in Chicago. Earlier this week, after
TOC had gone to press,
Strawdog announced it would be replacing its planned production of Arthur Miller's
All My Sons with Curt Columbus's translation of
The Cherry Orchard. The reason? As Strawdog's Nic Dimond told me today, it's because this fall's Broadway revival of
All My Sons might—
might—put out a tour, so Strawdog was denied the rights.
Read the print story
here, and my
TOC blog post about
All My Sons here. And even if you disagree with my conclusions, let me know what you think.
Elsewhere: Further advancing my own preference for more process transparency among theaters, audiences and critics, the
Tribune's Chris Jones, the
Reader's Tony Adler and Kerry Reid, who writes for both publications, sat down for a really interesting podcast interview with Talk Theatre's Anne Nicholson Weber.
Check it out here.
Recent Comments